World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
56
Citations
13196
World Ranking
3682
National Ranking
1447

Jeffrey McCullough publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Jeffrey McCullough sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 147 publications — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Jeffrey McCullough D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey McCullough sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 56 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Jeffrey McCullough is affiliated with the University of Minnesota in the United States. Their research primarily focuses on various aspects of medicine, with an emphasis on infectious diseases, biochemistry, hematology, and the management of technology and innovation. Epidemiology is also a notable area within their subfield studies.

The scientist has contributed to the following main topics of work:

  • Blood transfusion and management
  • COVID-19 Clinical Research Studies
  • Blood donation and transfusion practices
  • SARS-CoV-2 and COVID-19 Research
  • Blood groups and transfusion
  • Platelet Disorders and Treatments
  • Hepatitis B Virus Studies

McCullough's recent publications include:

  • Treatment for emerging viruses: Convalescent plasma and COVID-19 (2020, Transfusion and Apheresis Science)
  • Impact of different pathogen reduction technologies on the biochemistry, function, and clinical effectiveness of platelet concentrates: An updated view during a pandemic (2021, Transfusion)
  • SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022 (2023, Transfusion)
  • A crosswalk tabular review on methods and outcomes from randomized clinical trials using pathogen reduced platelets (2020, Transfusion)
  • Results of clinical effectiveness of conventional versus Mirasol-treated Apheresis Platelets in Patients with Hypoproliferative Thrombocytopenia (MiPLATE) trial (2024, Transfusion)

Their frequent coauthors include:

  • Paul M. Ness
  • Evan M. Bloch
  • Dorothy Kyeyune
  • Ronnie Kasirye
  • Ezra Musisi

Jeffrey McCullough's work has appeared predominantly in the journal Transfusion, with five publications. Other significant publication venues include Transfusion Medicine, UNC Libraries, Transfusion and Apheresis Science, and the International Journal of Public Health.

Best Publications

  • Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program

    Nancy A. Kernan;Glenn Bartsch;Robert C. Ash;Patrick G. Beatty

  • The big picture on nanomedicine: the state of investigational and approved nanomedicine products

    Michael L. Etheridge;Stephen A. Campbell;Arthur G. Erdman;Christy L. Haynes

  • A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant

    Raleigh A. Bowden;Sherrill J. Slichter;Sherrill J. Slichter;Sherrill J. Slichter;Merlin Sayers;Merlin Sayers;Merlin Sayers;Daniel Weisdorf;Daniel Weisdorf;Daniel Weisdorf

  • Dose of prophylactic platelet transfusions and prevention of hemorrhage.

    Sherrill J. Slichter;Richard M. Kaufman;Susan F. Assmann;Jeffrey McCullough

  • Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients

    Sherrill J. Slichter;Kathryn Davis;Helen Enright;Hayden Braine

  • Effects of Red-Cell Storage Duration on Patients Undergoing Cardiac Surgery

    Marie E. Steiner;Paul M. Ness;Susan F. Assmann;Darrell J. Triulzi

  • Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation : the SPRINT trial

    Jeffrey McCullough;David H. Vesole;Richard J. Benjamin;Sherrill J. Slichter

  • Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease.

    Wesley Miller;Patrick Flynn;Jeffrey McCullough;Henry H. Balfour

  • Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Charles A. Schiffer;Kari Bohlke;Meghan Delaney;Heather Hume

  • Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors.

    M P Busch;S H Kleinman;B Jackson;S L Stramer

  • Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection

    Thomas H. Price;Michael Boeckh;Michael Boeckh;Ryan W. Harrison;Jeffrey McCullough

  • Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome.

    SM Davies;XO Shu;BR Blazar;AH Filipovich

  • Treatment for emerging viruses: Convalescent plasma and COVID-19

    Unknown

  • A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

    J‐P. Cazenave;G. Folléa;L. Bardiaux;J.‐M. Boiron

  • Good manufacturing practices production of natural killer cells for immunotherapy: a six‐year single‐institution experience

    David H. McKenna;Darin Sumstad;Nancy Bostrom;Diane M. Kadidlo

  • Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.

    Edward Snyder;Jeffrey McCullough;Sherrill J Slichter;Ronald G Strauss

  • Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples.

    Vincent Laroche;David H. McKenna;Gary Moroff;Therese Schierman

  • Current status of cord blood banking and transplantation in the United States and Europe

    Karen Ballen;Hal E Broxmeyer;Jeffrey McCullough;Wanda Piaciabello

  • Patient care during infusion of hematopoietic progenitor cells.

    Annette Sauer-Heilborn;Diane Kadidlo;Jeffrey McCullough

  • Platelet utilization and the transfusion trigger: a prospective analysis.

    Edward Greeno;Jeffrey McCullough;Daniel Weisdorf

  • Biochemical characterization of the neutrophil-specific antigen NB1

    David F. Stroncek;Keith M. Skubitz;J. Jeffrey McCullough

  • Cyclic Leukocytosis in Chronic Myelogenous Leukemia: New Perspectives on Pathogenesis and Therapy

    Richard A. Gatti;William A. Robinson;William A. Robinson;Amos S. Deinard;Mark Nesbit

  • Studies of the kinetics of indium-111-labeled granulocytes.

    B. J. Weiblen;L. Forstrom;J. McCullough

Frequent Co-Authors

David F. Stroncek
David F. Stroncek National Institutes of Health
Paul M. Ness
Paul M. Ness Johns Hopkins University
Norma K.C. Ramsay
Norma K.C. Ramsay University of Minnesota
Paul G. Quie
Paul G. Quie University of Minnesota
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota
Robert J. Town
Robert J. Town The University of Texas at Austin
Ritu Agarwal
Ritu Agarwal Johns Hopkins University
John H. Kersey
John H. Kersey University of Minnesota
John E. Wagner
John E. Wagner University of Minnesota
Jon B. Christianson
Jon B. Christianson University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying Microbiology in the USA, related fields in health information and medical coding offer valuable career opportunities. A health information management bachelor degree salary reflects the growing demand for professionals who can effectively organize and manage healthcare data, combining science knowledge with information technology skills.

Students seeking flexible learning options might explore the best online cahiim accredited health information management degree programs, which provide specialized training and industry-recognized accreditation. These programs prepare graduates for roles that support healthcare systems through precise data handling and compliance with regulatory standards.

For accelerated entry into the medical administration field, an medical billing and coding certificate online accelerated can be an effective pathway. These programs offer quick certification to start careers focused on translating healthcare services into billing codes, crucial for organizational operations and insurance processes.

Additionally, many students wonder, what medical degrees can i get online. The availability of online medical degrees broadens access to healthcare education, enabling students to pursue clinical and administrative roles from remote locations. Exploring these options can complement a microbiology background and expand career possibilities within the healthcare sector.

Best Scientists Citing Jeffrey McCullough

Trending Scientists

Recently Published Articles